dr. reddy's labs glp-1 receptor agonist medications Dr Launches Oral Semaglutide in India Advances in GLP-1 receptor agonists
Description
Indication expansion, such as approvals for additional metabolic and cardiovascular conditions, is broadening patient access and driving adoption
Rotate placement daily to keep skin happy
Genetics integration available: Add the Precision Peptide Genetic Test post-purchase ($99 one-time) for genetic insights across 14 health pathways
The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.
Credits: istock.org
